Jun 29, 2018 6:15am EDT Lexaria Files New Patent Application for Enhancement of Delivery of Lipophilic Agents Across the Blood-Brain Barrier and Methods for Treating Central Nervous System Disorders
Apr 30, 2018 4:05pm EDT Lexaria Technology Brings "Fast-Acting" to Nuka’s 1906 Cannabis Products with 10-Year Deal Consummating Proof-of-Concept Relationship
Apr 17, 2018 5:40am EDT Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology
Mar 12, 2018 10:15am EDT Chris Bunka, CEO of Lexaria Bioscience Corp., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Discuss New Products and Company Evolution
Dec 18, 2017 8:00am EST Uptick Newswire “Stock Day” Interviews CEO of Lexaria on Cannabis Related Products and Recent Bioscience Patents
Oct 31, 2017 4:48pm EDT Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECH™ Delivery of THC, NSAIDs, Nicotine and Vitamins.
Aug 31, 2017 7:55am EDT University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria's TurboCBD(TM)
